Skip to main content

A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients with Chronic Migraine

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Headache and Pain

Awarded By

Alder BioPharmaceuticals, Inc.

Start Date

January 27, 2017

End Date

December 31, 2018
 

Administered By

Neurology, Headache and Pain

Awarded By

Alder BioPharmaceuticals, Inc.

Start Date

January 27, 2017

End Date

December 31, 2018